ATE382618T1 - R-(-)-1-[2-(7-chlorobenzo-[b -thiophen-3-yl- methoxy)-2-(2,4-dichlorphenyl)ethyl -1h-imidazol - Google Patents

R-(-)-1-[2-(7-chlorobenzo-[b -thiophen-3-yl- methoxy)-2-(2,4-dichlorphenyl)ethyl -1h-imidazol

Info

Publication number
ATE382618T1
ATE382618T1 AT03702597T AT03702597T ATE382618T1 AT E382618 T1 ATE382618 T1 AT E382618T1 AT 03702597 T AT03702597 T AT 03702597T AT 03702597 T AT03702597 T AT 03702597T AT E382618 T1 ATE382618 T1 AT E382618T1
Authority
AT
Austria
Prior art keywords
thiophen
imidazole
methoxy
ethyl
dichlorphenyl
Prior art date
Application number
AT03702597T
Other languages
English (en)
Inventor
Rafael Foguet
Jorge Ramentol
Antonio Guglietta
Celia Palacin
Luis Anglada
Original Assignee
Ferrer Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferrer Int filed Critical Ferrer Int
Application granted granted Critical
Publication of ATE382618T1 publication Critical patent/ATE382618T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AT03702597T 2002-02-11 2003-02-04 R-(-)-1-[2-(7-chlorobenzo-[b -thiophen-3-yl- methoxy)-2-(2,4-dichlorphenyl)ethyl -1h-imidazol ATE382618T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200200328A ES2203316B1 (es) 2002-02-11 2002-02-11 R-(-)-1-(2-(7-cloro-benzo(b)tiofen-3-il-metoxi)-2-(2,4-dicloro-fenil)-etil)1h-imidazol.

Publications (1)

Publication Number Publication Date
ATE382618T1 true ATE382618T1 (de) 2008-01-15

Family

ID=27675919

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03702597T ATE382618T1 (de) 2002-02-11 2003-02-04 R-(-)-1-[2-(7-chlorobenzo-[b -thiophen-3-yl- methoxy)-2-(2,4-dichlorphenyl)ethyl -1h-imidazol

Country Status (25)

Country Link
US (1) US7323433B2 (de)
EP (1) EP1474422B1 (de)
JP (1) JP5095070B2 (de)
KR (1) KR100701457B1 (de)
CN (1) CN1315824C (de)
AT (1) ATE382618T1 (de)
AU (1) AU2003205733B8 (de)
BR (1) BR0307754A (de)
CA (1) CA2474627C (de)
CO (1) CO5601026A2 (de)
DE (1) DE60318395T2 (de)
DK (1) DK1474422T3 (de)
ES (1) ES2203316B1 (de)
HK (1) HK1070883A1 (de)
IL (1) IL163452A (de)
MX (1) MXPA04007581A (de)
NO (1) NO327937B1 (de)
NZ (1) NZ534464A (de)
PL (1) PL211168B1 (de)
PT (1) PT1474422E (de)
RU (1) RU2276152C1 (de)
TN (1) TNSN04140A1 (de)
UA (1) UA78010C2 (de)
WO (1) WO2003068770A1 (de)
ZA (1) ZA200405941B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2249991B1 (es) * 2004-09-13 2007-03-01 Ferrer Internacional, S.A. Procedimiento de fabricacion de compuestos imidazolicos, sus sales y sus pseudopolimorfos.
ES2249992B1 (es) * 2004-09-13 2007-03-01 Ferrer Internacional, S.A. Un procedimiento para fabricar compuestos enantiomericos del imidazol.
EP1698336A1 (de) * 2005-03-01 2006-09-06 Ferrer Internacional, S.A. Antimykotischezusammensetzungen enthaltend Sertaconazol und entweder Hydrokortison oder einen antibakteriellen Wikrstoff
BRPI0922851A2 (pt) * 2008-12-09 2015-12-29 Ferrer Int polimorfo ii de um compsoto antifúngico
EP2436374A1 (de) * 2010-09-30 2012-04-04 Ferrer Internacional, S.A. Ovulus zur vaginalen Verabreichung von Arasertaconazol
EP2551351A1 (de) 2011-07-29 2013-01-30 Interquim, S.A. Verfahren zur Herstellung von optisch aktivem (R)-(-)-1-(2,4-dichlor-phenyl)-2-imidazol-1-yl-ethanol
CN102440947B (zh) * 2011-11-15 2012-12-26 海南海神同洲制药有限公司 硝酸舍他康唑乳膏剂
KR101717968B1 (ko) 2016-07-18 2017-03-20 씨앤아이 주식회사 스마트폰 결합 모듈
CN113480517B (zh) * 2021-07-30 2022-09-09 海南海神同洲制药有限公司 3-溴甲基-7-氯苯并[b]噻吩的合成方法
CN113735843B (zh) * 2021-09-07 2023-05-26 海南海神同洲制药有限公司 一种低熔点硝酸舍他康唑的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5135943A (en) * 1984-02-02 1992-08-04 Ferrer Internacional S.A. 1H-imidazole derivative compounds and pharmaceutical compositions containing the same
CA1250586A (en) * 1984-02-02 1989-02-28 Manuel Raga 1h-imidazole derivatives and process for their production
US5087620A (en) * 1990-05-17 1992-02-11 Bristol-Myers Squibb Co. Controlled dermal penetration enhancement using imidazoles
WO1996020939A1 (es) * 1995-01-04 1996-07-11 Ferrer Internacional, S.A. POLYMORFOS B Y C DE MONONITRATO DE 1-[2,4-DICLORO-β-[(7-CLOROBENZO[b]TIEN-3-IL)METOXI]FENETIL]IMIDAZOL

Also Published As

Publication number Publication date
KR100701457B1 (ko) 2007-03-29
US20050065201A1 (en) 2005-03-24
WO2003068770A1 (en) 2003-08-21
IL163452A (en) 2011-11-30
DK1474422T3 (da) 2008-05-13
US7323433B2 (en) 2008-01-29
TNSN04140A1 (en) 2007-03-12
CN1315824C (zh) 2007-05-16
JP2005524639A (ja) 2005-08-18
RU2276152C1 (ru) 2006-05-10
DE60318395D1 (de) 2008-02-14
CA2474627C (en) 2009-09-22
CN1630654A (zh) 2005-06-22
ES2203316B1 (es) 2005-03-01
NO20043377L (no) 2004-08-13
DE60318395T2 (de) 2009-01-02
PL370251A1 (en) 2005-05-16
CA2474627A1 (en) 2003-08-21
JP5095070B2 (ja) 2012-12-12
EP1474422A1 (de) 2004-11-10
RU2004127573A (ru) 2006-02-10
PL211168B1 (pl) 2012-04-30
UA78010C2 (uk) 2007-02-15
ZA200405941B (en) 2006-07-26
ES2203316A1 (es) 2004-04-01
HK1070883A1 (en) 2005-06-30
NZ534464A (en) 2006-02-24
EP1474422B1 (de) 2008-01-02
BR0307754A (pt) 2004-12-07
AU2003205733B2 (en) 2008-08-14
PT1474422E (pt) 2008-02-28
NO327937B1 (no) 2009-10-26
MXPA04007581A (es) 2004-11-10
AU2003205733B8 (en) 2008-09-04
CO5601026A2 (es) 2006-01-31
AU2003205733A1 (en) 2003-09-04
KR20040079996A (ko) 2004-09-16

Similar Documents

Publication Publication Date Title
HK1070883A1 (en) R-(-)-1-2-(7-chlorobenzo-b-thiophen-3-yl-methoxy)-2(2,4-dichlorophenyl)ethyl-1h-imidazole
HK1091481A1 (en) Therapeutic agents useful for treating pain
AP2000001942A0 (en) Use of organophosphoric compounds for the therapeutic and preventative treatment of infections.
BR0210122A (pt) Composto ou um sal farmaceuticamente aceitável do mesmo, método para o tratamento ou prevenção de uma doença, uso do composto ou de seu sal, e, método para preparar o mesmo
CA2378424A1 (en) Moxifloxacin formulation containing common salt
WO2004029031A3 (en) Therapeutic piperazine compounds
WO2004016086A3 (en) 2,4,5-trisubstituted imidazoles and their use as anti-microbial agents
MXPA05000765A (es) Compuestos de 5-ariltetrazola, composiciones de los mismos y usos para los mismos.
MY136449A (en) N-(3-methoxy-5-methylpyrazin-2-yl)-2-(4-[1,3,4-oxadiazol-2-yl]phenyl)pyridine-3-sulphonamide for the treatment of cancer
WO2000016757A8 (de) Verwendung von phosphororganischen verbindungen zur herstellung von arzneimitteln zur therapeutischen und prophylaktischen behandlung von infektionen oder als fungizid, bakterizid oder herbizid bei pflanzen
ATE260559T1 (de) Sordarinderivate
ATE344662T1 (de) Mittel enthaltend n-chlortaurin sowie dessen verwendung zur behandlung von schleimhautpolypen
WO2002055022A3 (en) Active metabolite of antifungal compound
BG104259A (en) Derivatives of 4-cyano-4-deformylsordaricin
WO2003007878A3 (en) Antifungal agents of sordarin derivatives
ATE241979T1 (de) 4-cyano-4-deformylsordarinderivate
BRPI0414319A (pt) agentes antibacterianos de quinolona
AP2001002164A0 (en) Use of phosphonoformic acid derivatives for treating infections.
MXPA05013760A (es) Composicion y procedimiento de tratamiento del platanero y del bananero.
ECSP003603A (es) Formulacion de sal comun y moxifloxacina

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1474422

Country of ref document: EP